Multicentric Kaposi's sarcoma in a 5-year-old human immunodeficiency virus-negative renal allograft recipient
Service de Réanimation Pédiatrique, Hopital Necker-Enfants Malades, Paris, FranceHuman Pathlogy (Impact Factor: 2.77). 09/1992; 23(8):956-960. DOI: 10.1016/0046-8177(92)90412-V
We describe the clinical and pathologic features of a case of pediatric multicentric Kaposi's sarcoma (KS) associated with allograft transplantation in a human immunodeficiency virus (HIV)-negative child. A lethal polyadenopathic and visceral KS occurred in a 5-year-old Caribbean boy who had undergone an allogenic renal transplantation for diffuse mesangial sclerosis with end-stage renal failure 4 months previously. The HIV-1 and HIV-2 serologies were negative. Despite its rarity, KS must be considered as a differential diagnosis in posttransplantation polyadenopathic or multisystemic syndromes in children.
- Archives of Dermatology 11/1993; 129(10):1320-3. DOI:10.1001/archderm.129.10.1320 · 4.79 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: Background: The main risk factor for Kaposi’s sarcoma is contact to the feces of sexual partners. The risk increases with the frequency of oral-anal contacts with different partners. Patient: We report a case of a white male homosexual with Kaposi’s sarcoma renal cell carcinoma without detectable HIV infection. The tumor was resected the patient is healthy still HIV-negative after a period of 3 years. Conclusion: The so-called ‘Kaposi agent’ is still unknown but may be of retroviral nature seems to be sexually transmissible.Onkologie 01/1995; 18(2):151-154. DOI:10.1159/000218577 · 0.86 Impact Factor
- Nephrology Dialysis Transplantation 07/1996; 11(6):1162-3. DOI:10.1093/oxfordjournals.ndt.a027478 · 3.58 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.